Renovaro increases authorized shares from 110M to 360M; common from 100M to 350M

Lunai Bioworks Inc.

Certificate of Amendment filed Feb 1, 2024, approved by stockholders on Jan 25, 2024.
Total authorized capital stock raised from 110,000,000 to 360,000,000 shares.
Authorized common stock increased from 100,000,000 to 350,000,000 shares.
No change to preferred stock authorization or par value ($0.0001) stated.
Purpose of increase not disclosed; may enable future financing or acquisitions.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Lunai Bioworks Inc.: Increased authorized shares from 110,000,000 to 360,000,000 and common stock from 100,000,000 to 350,000,000 (effective 2024-02-01).

Change: charter amendment
Effective: 2024-02-01

Exact text from the filing

On February 1, 2024, Renovaro Biosciences Inc., a Delaware corporation (the “Company”), filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Authorized Share Amendment”) to the Company’s Certificate of Incorporation, as amended, to increase the total number of authorized shares of capital stock of the Company from 110,000,000 to 360,000,000 and to increase the total number of authorized shares of common stock, par value $0.0001 per share, of the Company from 100,000,000 to 350,000,000, effective immediately.

View on SEC.gov

86 governance changes filed in the last 30 days. Browse all governance changes →

Lunai Bioworks Inc. filing history →

Source: SEC EDGAR

accession 0001731122-24-000207

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.